Immune complexes inhibit apoptosis of chronic lymphocytic leukaemia B cells

Br J Haematol. 1999 Dec;107(4):870-6. doi: 10.1046/j.1365-2141.1999.01759.x.

Abstract

In the present study we examined the effect of immune complexes (IC) on the survival of chronic lymphocytic leukaemia (B-CLL) B cells. Our results showed that either precipitating IC (pIC), Ab-coated erythrocytes (E-IgG) or heat-aggregated IgG (aIgG) significantly inhibited spontaneous apoptosis of B-CLL cells, as well as that induced by fludarabine, chlorambucil or dexamethasone. After depletion of T lymphocytes, monocytes and NK cells, incubation with IC was no longer able to delay B-CLL cells apoptosis, suggesting that prevention of apoptosis depends on IC interaction with accessory leucocytes. The release of IFNgamma by non-malignant cells upon activation with IC was responsible, to some extent, for IC effects as shown by the fact that neutralizing anti-IFNgamma MoAb partially prevented their ability to inhibit B-CLL cells apoptosis. The observation that treatment with IC resulted in increased expression of HLA-DR on B-CLL cells suggests that inhibition of apoptosis is associated with cellular activation.

MeSH terms

  • Antigen-Antibody Complex / immunology*
  • Apoptosis / immunology*
  • B-Lymphocytes / immunology
  • B-Lymphocytes / pathology*
  • Down-Regulation
  • HLA-DR Antigens / metabolism
  • Humans
  • Interferon-gamma / physiology
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Receptors, IgG / immunology

Substances

  • Antigen-Antibody Complex
  • HLA-DR Antigens
  • Proto-Oncogene Proteins c-bcl-2
  • Receptors, IgG
  • Interferon-gamma